COVID-19 Saliva Test Research Study
NCT04531501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2022-07-28
Summary
The objective of this study is to compare the Chronomics test against the NPS tests and protocol currently in use to demonstrate the efficacy of Chronomics' approach. The principal question is: Does the Chronomics saliva based test perform as well as the NPS NHS test?
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
Saliva and NPS test
N/A Our study will not impact their path of care as they will be doing an NHS test which will determine their path of care at the NHS
Sponsors & Collaborators
-
Chronomics Limited
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 117 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-29
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
- FDA Device
- Yes
Countries
- United Kingdom
Study Locations
More Related Trials
-
Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA
NCT04732637 ·Status: UNKNOWN
-
A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa
NCT05459532 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
NCT04522830 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Molecular OTC At Home Test
NCT05704803 ·Status: COMPLETED ·Phase: NA
-
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of HS-10517 in Chinese Adult Participants
NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
COVID SAFE: COVID-19 Screening Assessment for Exposure
NCT04508777 ·Status: COMPLETED
-
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
NCT04328961 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
Intranasal INNA-051 for Prevention of COVID-19 in Adults
NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2
-
PROLIFIC ChemoprophylaxisTrial (COVID-19)
NCT04352933 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
NCT04637828 ·Status: UNKNOWN ·Phase: PHASE2
-
Real World COVID-19 Antiviral Effectiveness Research
NCT05638919 ·Status: UNKNOWN
-
The Efficacy and Safety of Azovudine in the Treatment of COVID-19
NCT05675761 ·Status: UNKNOWN
-
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
NCT04360551 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of ES16001 in Patients With COVID-19
NCT05525182 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient
NCT04595136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
SARS-CoV-2 Human Challenge Characterisation Study
NCT04865237 ·Status: COMPLETED ·Phase: NA
-
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
NCT05787418 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)
NCT06360757 ·Status: TERMINATED
-
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
NCT04535167 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
COVID-19 Prophylaxis South Africa (COVER HCW)
NCT04561063 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
NCT04847622 ·Status: COMPLETED
-
Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over
NCT05745545 ·Status: UNKNOWN ·Phase: NA